CBU
BIIB icon

CIBC Bancorp USA’s Biogen BIIB Stock Holding History

CIBC Bancorp USA’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.25M Sell
33,539
-8,363
-20% -$1.6M 0.01% 634
2026
Q1 		$7.68M Buy
+41,902
New +$7.72M 0.01% 590
2025
Q3 		$3.59M Buy
+25,593
New +$3.46M 0.02% 471

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CIBC Bancorp USA's BIIB Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Biogen (BIIB) stake by 20% in Q2 2026, selling an estimated $1.6M and leaving 33,539 shares worth $7.25M. The position accounts for 0.01% of the portfolio, ranked #634.

CIBC Bancorp USA first reported a position in BIIB in Q3 2025 and has held it in 3 quarters since. The position peaked at $7.68M in Q1 2026. 981 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • CIBC Bancorp USA held 33,539 shares of Biogen worth $7.25M as of Q2 2026.
  • CIBC Bancorp USA sold 8,363 Biogen shares in Q2 2026, an estimated $1.6M.
  • Biogen made up 0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #634 holding.
  • CIBC Bancorp USA first reported a position in Biogen in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Biogen position peaked at $7.68M in Q1 2026.
  • 981 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.